๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine

โœ Scribed by F. Zoulim; T. Poynard; F. Degos; A. Slama; A. El Hasnaoui; P. Blin; F. Mercier; P. Deny; P. Landais; P. Parvaz; C. Trepo; The Lamivir Study Group

Book ID
108885870
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
127 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Mutations associated with the therapeuti
Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis
โœ Kazuyoshi Ohkawa; Tetsuo Takehara; Michio Kato; Aimi Kanada; Matsuo Deguchi; Mas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 269 KB

## Abstract Factors influencing the therapeutic efficacy of adefovir dipivoxil added to continuing lamivudine have not been elucidated in lamivudineโ€resistant patients with type B chronic hepatitis. The viral mutations influencing the efficacy of treatment with adefovir dipivoxil were investigated

Association of lamivudine-resistant muta
Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B
โœ Choong Keun Cha; Hyeok Choon Kwon; Jae Youn Cheong; Sung Won Cho; Sun Pyo Hong; ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 2 views

## Abstract Adefovir has a potent antiviral activity as a rescue treatment against lamivudineโ€resistant strains. The aim of this study was to assess the patterns of lamivudineโ€resistant mutations and their influence on the virologic response to adefovir rescue therapy in patients with lamivudineโ€re

Loss of hepatitis B surface antigen from
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine
โœ Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Tetsuya Hosaka; Hitomi Sezaki; H ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB ๐Ÿ‘ 1 views

## Abstract Although loss of hepatitis B e antigen (HBeAg) from the serum is sought by treatment with lamivudine, clearance of hepatitis B surface antigen (HBsAg) is the eventual goal of any antiviral therapy. In a single hepatology center in the Metropolitan Tokyo, 486 patients with chronic hepati